CLINDAMYCIN HYDROCHLORIDE CAPSULES
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP26F8922 to DMS Pharmaceutical Group Inc on August 13, 2026. This award is a delivery order under the primary contract SPE2DX25D9900 and is valued at 344.04 dollars. The scope of the contract involves the procurement of Clindamycin Hydrochloride Capsules, identified by national stock number 6505012904628 and purchase request 7017888938. The award was managed by the Department of Defense through the DLA.
General Info
Agency
Contract Value
$344.04NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
